Is Overall Sentiment on NANO-X IMAGING LTD Bearish?

This morning we watched NANO-X IMAGING LTD drop -1.6% to a price of $17.51 per share. The small-cap Medical Electronics company is now trading -45.28% below its average target price of $32.0. Analysts have set target prices ranging from $30.0 to $34.0 per share for NANO-X IMAGING LTD, and have given the stock an average rating of buy.

NANO-X IMAGING LTD has an elevated short interest of 13.8%. The stock's short ratio, or the number of days needed for all shorts to cover their positions, is 1.55. 14.01% of the corporation's outstanding shares are owned by its managers and directors, indicating a strong degree of alignment between their interests and those of other shareholders. NANO-X IMAGING LTD's rate of institutional ownership is 17.5%, which indicates a decent level of confidence in the stock. Based on these factors, Market Inference considers NANO-X IMAGING LTD to be the target of mixed market sentiment.

Institutions Invested in NANO-X IMAGING LTD

Date Reported Holder Percentage Shares Value
2023-03-31 Blackrock Inc. 6% 3,050,855 $53,420,471
2023-03-31 State Street Corporation 2% 970,253 $16,989,130
2023-03-31 Credit Suisse Ag/ 1% 677,932 $11,870,589
2023-03-31 Morgan Stanley 1% 491,840 $8,612,118
2023-03-31 Geode Capital Management, LLC 1% 489,759 $8,575,680
2023-03-31 VK Services, LLC 1% 426,844 $7,474,038
2023-03-31 Susquehanna International Group, LLP 1% 393,993 $6,898,817
2023-03-31 Johnson & Johnson 1% 317,704 $5,562,997
2023-03-31 Northern Trust Corporation 1% 301,177 $5,273,609
2023-03-31 ARK Investment Management, LLC 0% 255,542 $4,474,540
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS